Reversing Caremark recoupments. Reinstating terminated pharmacies.
CVS Caremark runs one of the most aggressive PBM audit programs in the United States. A single flagged claim can trigger six- and seven-figure recoupments, termination for cause, and downstream loss of Aetna commercial, SilverScript Medicare Part D, and CVS Pharmacy network access. We defend pharmacies nationwide before the audit closes. Every day of delay changes your settlement posture.
.png)
By the time the Caremark notice arrives, the downstream exposure is already stacked. Here is what your pharmacy is actually defending against.
Caremark audit findings routinely demand recoupments of $250K to $4M+ per matter, with the audit team aggressively extrapolating a sampled-claim error rate across 12 to 24 months of total dispensing. Defense requires challenging both the sampled findings and the extrapolation methodology.
A Caremark termination for cause designation flows downstream across the entire CVS Health enterprise: Aetna commercial, SilverScript Medicare Part D, and the CVS Pharmacy network operated by the parent. Credentialing impact across multiple payors typically lands within 30 days of the termination notice.
CVS Caremark audit findings on controlled substances, compounding, and high-cost specialty claims are routinely referred to DEA, DOJ, HHS-OIG, and state boards of pharmacy. A PBM finding can become a civil investigative demand, a state board complaint, or a federal healthcare fraud investigation within weeks.
Four factors make CVS Caremark recoupments uniquely dangerous, and uniquely defensible if you know where CVS Caremark is actually vulnerable.
Our bench includes a former Assistant U.S. Attorney (DOJ Director's Award recipient) and senior PBM operational counsel. We have run more than 1,500 pharmacy audits across the major PBMs, including Caremark. This is how we dismantle a Caremark audit.
Within 24 hours: parse every deadline in the Caremark audit notice, place a litigation hold on the claims at issue, and preserve adjudication logs and signature records before Caremark's evidentiary window narrows.
Claim-by-claim reconstruction at the NDC level: prescriber PA rationale, formulary tier at time of fill, step therapy requirements documented or overridden, plan criteria at time of fill, DAW code support, signature log validation, and controlled substance recordkeeping. Every flagged claim gets its own defense memo tied back to the Caremark provider manual citation.
We draft and file the written Caremark appeal, quantify the extrapolation errors, and negotiate directly with the Caremark audit team and provider relations on behalf of the pharmacy.
If Caremark refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, HHS-OIG, and the state board so a PBM dispute does not escalate into a license action or a criminal referral.
If any of these describe your 2024 to 2026 Caremark-billed dispensing activity, you are already in the Caremark audit pool whether or not the notice has arrived.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Network Reinstated
A compounding pharmacy received a Caremark termination for cause tied to compounded GLP-1 dispensing during the FDA shortage period. HLA's appeal brief documented compliance with the 503A pathway in effect on the dispense dates, addressed the OON appeal procedural record, and obtained full reinstatement across Caremark, SilverScript, and Aetna without a recoupment.
Recoupment Reversed
A multi-location independent pharmacy faced a Caremark specialty audit citing DAW code mismatches and signature log gaps across 18 months of dispenses. HLA reconstructed the underlying claims, challenged the extrapolation methodology, and negotiated a final settlement substantially below the original recoupment demand.
State Board Closed
A Caremark on-site audit produced a state board of pharmacy referral alleging recordkeeping and dispensing violations. HLA's regulatory response addressed each cited deficiency and documented compliance with the state pharmacy practice act on the dispense dates; the board closed the matter with no discipline.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific audit.
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
Eight questions that come up on almost every first call.
Before you write a single page of your Caremark response, have a privileged conversation with attorneys who have overseen 1,500+ pharmacy audits across the major PBMs, including reversed Caremark terminations and reduced Caremark recoupments. Free, confidential, no retainer.
